ERBB2 and breast cancer: Moreover, in vivo analyses of human breast cancer have confirmed that the amplification of ErbB2 in combination with the overexpression of p130Cas induces a higher proliferation rate and an increased number of distant metastases as well as correlating with poor prognosis5, 7.